Biogen Is Dropping Controversial Alzheimer ' s Drug Aduhelm

WEDNESDAY, Jan. 31, 2024 -- Biogen, maker of the Alzheimer ' s medicine Aduhelm, announced Wednesday that it would " discontinue the development and commercialization " of the controversial drug.Biogen will return the rights to Aduhelm to Neurimmune,...

Source: Drugs.com - Daily MedNews - January 31, 2024 Category: General Medicine Source Type: news